You just read:

Real-World Data from Boehringer Ingelheim Show Lower Risk of Stroke and Major Bleeding for Pradaxa® (dabigatran etexilate mesylate) Compared to Warfarin

News provided by

Boehringer Ingelheim Pharmaceuticals

Feb 24, 2017, 08:00 ET